The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives

References

• SecadesJJFronteraGCDP-choline: pharmacological and clinical reviewMethods Find Exp Clin Pharmacol199517suppl B1548709678
   PubMedGoogle Scholar
• FioravantiMYanagiMCytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderlyCochrane Database Syst Rev2005182CD00026915846601
   PubMedGoogle Scholar
• HurtadoOLizasoainIMoroMÁNeuroprotection and recovery: recent data at the bench on citicolineStroke201142suppl1S33S3521164125
   PubMed Web of Science ®Google Scholar
• GriebPNeuroprotective properties of citicoline: facts, doubts and unresolved issuesCNS Drugs201428318519324504829
   PubMed Web of Science ®Google Scholar
• Alvarez-SabínJOrtegaGJacasCLong-term treatment with citicoline may improve poststroke vascular cognitive impairmentCerebrovasc Dis201335214615423406981
   PubMed Web of Science ®Google Scholar
• SecadesJJCiticoline: pharmacological and clinical review, 2010 updateRev Neurol201152suppl 2S1S6221432836
   PubMed Web of Science ®Google Scholar
• Alvarez-SabinJRomanGCCiticoline in vascular cognitive impairment and vascular dementia after strokeStroke201142S40S4321164117
   PubMed Web of Science ®Google Scholar
• García-CobosRFrank-GarcíaAGutiérrez-FernándezMDíez-TejedorECiticoline, use in cognitive decline: vascular and degenerativeJ Neurol Sci20102991–218819220875651
   PubMed Web of Science ®Google Scholar
• FioravantiMBuckleyAECiticoline (Cognizin) in the treatment of cognitive impairmentClin Interv Aging20061324725118046877
   PubMed Web of Science ®Google Scholar
• PutignanoSGareriPCastagnaARetrospective and observational study to assess the efficacy of citicoline in elderly patients suffering from stupor related to complex geriatric syndromeClin Interv Aging2012711311822654511
   PubMed Web of Science ®Google Scholar
• CotroneoAMCastagnaAPutignanoSEffectiveness and safety of citicoline in mild vascular cognitive impairment: the IDEALE studyClin Interv Aging2013813113723403474
   PubMed Web of Science ®Google Scholar
• SecadesJJLorenzoJLCiticoline: pharmacological and clinical review, 2006 updateMethods Find Exp Clin Pharmacol200628suppl B15617171187
   PubMedGoogle Scholar
• Franco-MasideACaamañoJGómezMJCacabelosRBrain mapping activity and mental performance after chronic treatment with CDP-choline in Alzheimer’s diseaseMethods Find Exp Clin Pharmacol19941685976077760585
   PubMedGoogle Scholar
• CaamañoJGómezMJFrancoACacabelosREffects of CDP-choline on cognition and cerebral hemodynamics in patients with Alzheimer’s diseaseMethods Find Exp Clin Pharmacol19941632112187913981
   PubMedGoogle Scholar
• Fernández-NovoaLAlvarezXAFranco-MasideACaamañoJCacabelosRCDP-choline-induced blood histamine changes in Alzheimer’s diseaseMethods Find Exp Clin Pharmacol19941642792848051988
   PubMedGoogle Scholar
• CacabelosRAlvarezXAFranco-MasideAFernández-NovoaLCaamañoJEffect of CDP-choline on cognition and immune function in Alzheimer’s disease and multi-infarct dementiaAnn N Y Acad Sci19936953213238239305
   PubMed Web of Science ®Google Scholar
• AlvarezXAMouzoRPichelVDouble-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer’s disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusionMethods Find Exp Clin Pharmacol199921963364410669911
   PubMedGoogle Scholar
• BellizziDDatoSCavalcantePCharacterization of a bidirectional promoter shared between two human genes related to aging: SIRT3 and PSMD13Genomics200789114315017059877
   PubMed Web of Science ®Google Scholar
• DonmezGSirtuins as possible targets in neurodegenerative diseasesCurr Drug Targets20131464464723410123
   PubMed Web of Science ®Google Scholar
• DonmezGGuarenteLAging and disease: connections to sirtuinsAging Cell2010928529020409078
   PubMed Web of Science ®Google Scholar
• MaCYYaoMJZhaiQWJiaoJWYuanXBPooMMSIRT1 suppresses self-renewal of adult hippocampal neural stem cellsDevelopment20141414697470925468938
   PubMed Web of Science ®Google Scholar
• KimSHLuHFAlanoCCNeuronal SIRT3 protects against excitotoxic injury in mouse cortical neuron culturePLoS One20116e1473121390294
   PubMed Web of Science ®Google Scholar
• D’AquilaPRoseGPannoMLPassarinoGBellizziDSIRT3 gene expression: a link between inherited mitochondrial DNA variants and oxidative stressGene2012497232332922326535
   PubMed Web of Science ®Google Scholar
• ZhangFWangSGanLProtective effects and mechanisms of sirtuins in the nervous systemProg Neurobiol20119537339521930182
   PubMed Web of Science ®Google Scholar
• DonmezGWangDCohenDGuarenteLSIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10Cell201014232033220655472
   PubMed Web of Science ®Google Scholar
• DonmezGOuteiroTFSIRT1 and SIRT2: emerging targets in neurodegenerationEMBO Mol Med2013534435223417962
   PubMed Web of Science ®Google Scholar
• MinSWChoSHZhouYAcetylation of tau inhibits its degradation and contributes to tauopathyNeuron20106795396620869593
   PubMed Web of Science ®Google Scholar
• DonmezGThe neurobiology of sirtuins and their role in neurodegenerationTIPS201233949450122749331
   PubMed Web of Science ®Google Scholar
• AlbensiBCMattsonMPEvidence for the involvement of TNF and NF-kB in hippocampal synaptic plasticitySynapse201035215115910611641
   PubMed Web of Science ®Google Scholar
• DonmezGArunAChungCYMcLeanPJLindquistSGuarenteLSIRT1 protects against α-synuclein aggregation by activating molecular chaperonesJ Neurosci201232112413222219275
   PubMed Web of Science ®Google Scholar
• PolitoLKehoePGDavinAThe SIRT2 polymorphism rs10410544 and risk of Alzheimer’s disease in two Caucasian case control cohortsAlzheimers Dement20139439239922651940
   PubMed Web of Science ®Google Scholar
• HurtadoOHernández-JiménezMZarrukJGCiticoline (CDP-choline) increases Sirtuin1 expression concomitant to neuroprotection in experimental strokeJ Neurochem2013126816819
   Web of Science ®Google Scholar
• GrozingerCMChaoEDBlackwellHEMoazedDSchreiberSLIdentification of a class of small molecule inhibitors of the sirtuin family and NAD-dependent deacetylases by phenotypic screeningJ Biol Chem2001276388373884311483616
   PubMed Web of Science ®Google Scholar
• Hernández-JiménezMHurtadoOCuarteroMISilent information regulator 1 (SIRT1) protects the brain against cerebral ischemic damageStroke20134482333233723723308
   PubMed Web of Science ®Google Scholar
• KrupinskiJSlevinMBadimonLCiticoline inhibits MAP kinase signalling pathways after focal cerebral ischaemiaNeurochem Res20053081067107316258856
   PubMed Web of Science ®Google Scholar
• Lozano-FernandezREfficacy and safety of oral CDP-choline. Drug surveillance study in 2,817 casesArzneimittelforschung1983337A107310806684470
   PubMed Web of Science ®Google Scholar
• SecadesJJCDP-choline: update and review of its pharmacology and clinical useMethods Find Exp Clin Pharmacol200224suppl B153
   Google Scholar
• CacabelosRCaamañoJGómezMJFernández-NovoaLFranco-MasideAAlvarezXATherapeutic effects of CDP-choline in Alzheimer’s disease. Cognition, brain mapping, cerebrovascular hemodynamics, and immune factorsAnn N Y Acad Sci19967773994038624120
   PubMed Web of Science ®Google Scholar
• van SwietenJCKoudstaalPJVisserMCSchoutenHJvan GijnJInterobserver agreement for the assessment of handicap in stroke patientsStroke19881956046073363593
   PubMed Web of Science ®Google Scholar
• LydenPBrottTTilleyBImproved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study GroupStroke19942511222022267974549
   PubMed Web of Science ®Google Scholar
• KasnerSEChalelaJALucianoJMReliability and validity of estimating the NIH stroke scale score from medical recordsStroke19993081534153710436096
   PubMed Web of Science ®Google Scholar
• SulterGSteenCDe KeyserJUse of the Barthel Index and modified Rankin Scale in acute stroke trialsStroke19993081538154110436097
   PubMed Web of Science ®Google Scholar
• ZafonteRDBagiellaEAnselBMEffect of citicoline on functional and cognitive status among patients with traumatic brain injury: citicoline brain injury treatment trial (COBRIT)JAMA2012308191993200023168823
   PubMed Web of Science ®Google Scholar
• DávalosAAlvarez-SabínJCastilloJInternational Citicoline Trial on acUte Stroke (ICTUS) trial investigatorsCiticoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial)Lancet2012380983934935722691567
   PubMed Web of Science ®Google Scholar
• D’OrlandoKJSandageBWJrCiticoline (CDP-choline): mechanism of action and effects in ischemic brain injuryNeurol Res1995172812847477743
   PubMed Web of Science ®Google Scholar
• DinsdaleJRGriffithsGKCastellóJMaddockJOrtizJAAylwardMCDP-choline: repeated oral dose tolerance studies in adult healthy volunteersArzneimittelforschung1983337A106110656684468
   PubMed Web of Science ®Google Scholar